Access to Over the Counter (OTC) Drug Utilization Data
Contact and place of performance
Benjamin Golway
Silver Spring, MD 20993
USA
05/28/2020 - Amendment2 to FDA-RFP-1228764"Access to Over-the-Counter (OTC) Drug Utilization Data/Services" is posted to revise evaluation Factor 3. Pleaserefer to the attached RFP (Amendment 2). RFP revisions are highlighted in yellow in Amendment 2.
The Food and Drug Administration (FDA) Office of Acquisition and Grant Services is seeking access to Over-the-Counter (OTC) drug utilization data and related services. This requirement is categorized under NAICS 541519 for Other Computer Related Services and PSC DA10 for IT and Telecom - Business Application/Application Development Software as a Service. The primary objective of this solicitation is to provide the agency with specialized data resources to monitor and analyze the utilization of non-prescription medications.
This combined synopsis and solicitation, issued under solicitation number FDA-RFP-1228764, specifies a place of performance in Silver Spring, Maryland. A recent amendment to the solicitation revised the evaluation criteria specifically for Factor 3, as detailed in the five supporting documents which include the original request for proposals in both PDF and Word formats, a question-and-answer summary, and two subsequent amendments.
The response deadline for this opportunity is June 8, 2020. The procurement process is managed by Benjamin Golway at the FDA. Interested parties must adhere to the instructions within the formal solicitation documents, which outline the necessary software-as-a-service capabilities and data access requirements needed to support the agency's mission.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.